Status:
UNKNOWN
Biomarkers, Genomics, Physiology in Critically Ill and ECMO Patients
Lead Sponsor:
University of California, San Diego
Conditions:
Acute Respiratory Distress Syndrome
Cardiac Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients in end-stage cardiac failure and/or respiratory failure may be started on a rescue therapy known as Extracorporeal Membrane Oxygenation (ECMO). One of the major clinical questions is how to m...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patient currently on ECMO (Veno-Venous or Venous-Arterial or Venous-Arterial-Venous)
- Patient that is a potential ECMO candidate.
- Exclusion Criteria
- History of Lung or Cardiac Transplantation
- Patient is not committed to full support
- Treating clinician refusal, or unwillingness to commit to controlled ventilation for at least 4-6 hours (if patient is mechanically ventilated)
- Inability to get informed consent from the patient or surrogate.
Exclusion
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04669444
Start Date
April 14 2020
End Date
March 1 2023
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Diego Health
La Jolla, California, United States, 92037-7381